The patient is a 40-year old male alcohol abuser presenting with abdominal pain, vomiting, and distension. Investigations show elevated lipase and CT scan shows bulky pancreas and gallbladder sludge. The patient meets criteria for acute pancreatitis and CT severity index of 8/10 suggests severe disease. While antibiotics are not routinely recommended, they may be considered for infected necrosis seen on imaging or clinical deterioration. Aggressive fluid resuscitation and pain management with tramadol are the primary treatments, with nutritional support and monitoring for organ dysfunction.
Surgical management of hepatic hydatid diseaseKETAN VAGHOLKAR
Hydatidosis is strictly a zoonosis. Humans are an accidental host. The disease is endemic in rural agricultural areas. However if acquired by humans, it can cause extensive spread affecting a wide range of organs with predilection for the liver. Managing such cases requires a sound fundamental knowledge of the parasite and its pathogenicity. It is essential that surgeons who deal with such cases have a good working knowledge of the disease. The approaches to hepatic hydatids with respect to the principles of surgical treatment are presented in this article.
Gastroesophageal reflux disease (GERD) is defined as the failure of the antireflux barrier, allowing abnormal reflux of gastric contents into the esophagus. It is a condition which develops when the reflux of stomach contents causes troublesome symptoms and complications.
Surgical management of hepatic hydatid diseaseKETAN VAGHOLKAR
Hydatidosis is strictly a zoonosis. Humans are an accidental host. The disease is endemic in rural agricultural areas. However if acquired by humans, it can cause extensive spread affecting a wide range of organs with predilection for the liver. Managing such cases requires a sound fundamental knowledge of the parasite and its pathogenicity. It is essential that surgeons who deal with such cases have a good working knowledge of the disease. The approaches to hepatic hydatids with respect to the principles of surgical treatment are presented in this article.
Gastroesophageal reflux disease (GERD) is defined as the failure of the antireflux barrier, allowing abnormal reflux of gastric contents into the esophagus. It is a condition which develops when the reflux of stomach contents causes troublesome symptoms and complications.
Acute Pancreatitis (According to American College of Gastroenterology 2013 gu...Jibran Mohsin
This Presentation focuses on definition, new classification, different scoring systems for severity, rationale for radiological signs and new management recommendations as per 2013 American College of Gastroenterology guidelines
Pancreatitis is a dreaded condition associated with development of acute and sudden inflammation of the pancreas.
Pancreatic enzymes are released in the abdomen and cause inflammation by the damage from digestion of normal body structures, especially fat in the abdomen.
Mortality ranges from 3 percent in patients with interstitial edematous pancreatitis to 17 percent in patients who develop pancreatic necrosis.
Pancreatitis - being one of the differentials for acute abdomen which includes Acute & Chronic pancreatitis, their aetiology, pathogenesis, clinical features & possible complications.
Dr Anil Arora address the liver diseases that are specific during pregnancy. The presentation contains case discussions on diagnosis, treatments & take home messages
Dr Neerav Goyal discusses the various aspects of acute liver failure that includes the criteria, pre transplant issues, critical care management, overall survival.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfJim Jacob Roy
Cardiac conduction defects can occur due to various causes.
Atrioventricular conduction blocks ( AV blocks ) are classified into 3 types.
This document describes the acute management of AV block.
2. Index Case
24May 2016
40 yrs old male, alcohol abuser presented with
►Pain abdomen for 3 hours
Upper abd, non-colicky, severe, radiating to back
Associated vomiting, multiple time bilious
Associated abd distension +
►Past, Family History : Not significant
►Personal History: 80-100 gms of alcohol/day for 15-16
yrs
3. GPE – Pulse 122 , BP 140/82 mmHg, RR 24/min
Abdomen
►Liver 3 cm, soft to firm
►Spleen not palpable
►Diffuse tenderness & guarding in whole abdomen
►Bowel sound sluggish
Chest: reduced breath sound at bases
CVS, CNS – NS
Possibilities:
Index Case
4. Index case: Investigations
Hb -15.5 TLC – 14000 DLC – N 76 L 22 Platelets –
355
Urea : 55 Creatininine : 1.2
Bil – 1.5 SGOT – 55 SGPT – 62 ALP 130 (ULN – 128)
TP – 7.6 Albumin – 4.9
Amylase – 155 (40-140)
Lipase – 96 (0-50)
Abd X-ray: No evidence of pneumoperitoneum
USG abdomen – Bulky pancreas, GB sludge
5. Issue 1
What is the practically acceptable criteria
for diagnosis of acute pancreatitis?
6. Acute pancreatitis: Diagnosis
At least two of the following
►Abdominal pain consistent with the disease
►Serum amylase and / or lipase greater than three
times the upper limit of normal
►Characteristic findings from abdominal imaging
CECT and / or MRI should be reserved for
►Patients in whom the diagnosis is unclear
►Who fail to improve clinically within the first 48 – 72 h
after hospital admission
►To evaluate complications
ACG Guideline. Am J Gastroenterol 2013; 108:1400–1415
7. Issue 2
Which enzyme assay is preferable : amylase or
lipase or combination of two?
►Relative accuracy
►False negative and false positive
8. Pattern of rise
►Rises within a few hours, may return to normal within 5
days
►Sensitivity in AP – approx 80%
Acute pancreatitis with no rise in amylase
►Hypertriglyceridemia
►Alcohol related AP
►Acute on chronic pancreatitis
High amylase but no pancreatitis
►Macroamylasemia
►Renal failure
►diseases of the salivary glands
►Extrapancreatic abdominal conditions with inflammation
►Gynaecological diseases
Serum amylase estimation: Pitfalls
10. Pancreatic enzyme testing in AP
Amylase testing offers no additional value to
lipase testing
Dual testing is not superior to Lipase testing
alone
Neither have prognostic value
Pancreatic enzymes should not be repeated
after making the diagnosis of acute pancreatitis
Barbieri JS. Journal of Hospital Medicine 2016;11 :366-68
11. Index case
Repeat Lipase at 24 hours : 480 IU
Diagnosis of Acute pancreatitis was made
Treatment
►IV fluid
►Analgesia
12. Issue 3
Fluid for initial resuscitation/therapy of acute
pancreatitis?
►Does initial aggressive fluid resuscitation matter?
►Which the preferred or currently recommended
crystalloid fluid in initial management of acute of
pancreatitis?
►How to monitor fluid resuscitation?
Non-invasively – clinical/lab parameter
Invasively
How frequently the fluid therapy should be
monitored?
13. Fluid therapy in acute pancreatitis
Aggressive hydration, defined as 250 – 500 ml per hour
of isotonic crystalloid solution unless contraindicated
Early aggressive intravenous hydration is most beneficial
during the first 12 – 24 hrs
In a patient with severe volume depletion, manifest as
hypotension and tachycardia, more rapid repletion
(bolus) may be needed
ACG Guideline. Am J Gastroenterology 2013
14. Lactated Ringer ’ s solution may be the preferred isotonic
crystalloid replacement fluid
Fluid requirements should be reassessed at frequent
intervals within 6 h of admission and for the next 24 – 48
h.
The goal of aggressive hydration should be to decrease
the BUN
CVP/USG monitoring of IVC
Fluid therapy in acute pancreatitis
ACG Guideline. Am J Gastroenterology 2013
15. IV line secured, started on RL
NPO
Injectable PPI – Pantoprazole 80 mg followed
by 40 mg BD
Inj Metoclopramide 10 mg IV stat
Analgesic: Buscopan + Diclofenac injection –
pain reduced in intensity but did not subside
Index case: Investigations
17. Effect of narcotics on Sphincter of Oddi
pressure
Sphincter
pressure at base
line
Sphincter
pressure 20 min
after inj
Morphine 8.90±9.11 20.51±13.46
Pethidine 7.06±5.07 6.68±4.32
Tramadol 7.01±5.50 6.39±5.37
Pentazocine 6.42±5.10 11.34±8.40
Wu SD. World J Gastroenterol 2004;10(19):2901-2904
18. Effect of narcotics on Sphincter of Oddi
pressure
Staritz M et al. Gut, 1986, 27, 567-569
19. Morphine and pentazocine increase SO and
CBD pressure
Pethidine does not increase SO or bile duct
pressure
Tramadol and Buprenorphine increase SO
pressure minimally
Tramadol has the same analgesic effect as
morphine. But it has little effect on the
respiratory system and circulation system
Effect of narcotics on Sphincter of Oddi
pressure
Wu SD. World J Gastroenterol 2004;10(19):2901-2904
20. Pain persisted in lower intensity – was put on Inj Tramadol
sos, Buprenorphine patch was given
Started having fever from Day 3 – Temp upto 38.5 degrees C
Bowel not moved
Tachypnea – RR 24-30, O2 – 0.30
Repeat Labs on day 4
►S/Electrolytes, RFT – N
►LFT – Bil – N, Mild rise of transaminases
►Hb 12.9 gms TLC -13500 DLC – N 70 L 26
Index case: Course
21. Issue 5
How do we define severity of acute
pancreatitis?
►Mild/moderate/severe
22. Revised Atlanta Definitions 2012
Interstitial oedematous pancreatitis
►Acute inflammation of the pancreatic parenchyma and
peripancreatic tissues, but without recognisable tissue
necrosis
►CECT criteria
Pancreatic parenchyma enhancement by intravenous
contrast agent
No findings of peripancreatic necrosis
Necrotizing pancreatitis
►Inflammation associated with pancreatic parenchymal
necrosis and/or peripancreatic necrosis
►CECT criteria
Lack of pancreatic parenchymal enhancement by
intravenous contrast agent and/or
Presence of findings of peripancreatic necrosis
23. Mild acute pancreatitis
►No organ failure
►No local or systemic complications
Moderately severe acute pancreatitis
►Organ failure that resolves within 48 h
►Transient organ failure and/or
►Local or systemic complications without
persistent organ failure
Severe acute pancreatitis
►Persistent organ failure (>48 h)
Single organ failure
Multiple organ failure
Severity of acute pancreatitis
24. Parameters
Score
0 1 2 3 4
PaO2/ FiO2 ratio >400 301–400 201–300 101–
200
≤101
Serum creatinine,
mg/dl)
<1.4 1.4–1.8 1.9–3.6 3.6–4.9 >4.9
Cardiovascular
(systolic blood
pressure, mm)
>90 <90, fluid
responsive
<90, not
fluid
responsive
<90,
pH<7.3
<90,
pH<7.
2
Modified Marshall scoring system for organ
dysfunction
A score of 2 or more in any system defines the presence of organ failure.
25. Organ failure in acute pancreatitis
Shock
►(systolic blood pressure < 90 mm Hg),
Pulmonary insufficiency
► (PaO 2 < 60 mm Hg),
Renal failure
►creatinine > 2 mg / dl after rehydration
Gastro intestinal bleeding
► > 500 ml of blood loss/ 24 h
Bradley EL et al. Arch Surg 1993 ; 128 : 586 –
33. Issue 6
Is this patient having severe acute pancreatitis
or likely to have severe acute pancreatitis?
How to identify patients with severe acute
pancreatitis?
37. Japanese society severity score
Variables
►BE level < -3 mEq/L or shock
►PaO2 < 60 mm Hg (room air) or respiratory failure
►Blood urea nitrogen level > 40 mg/dL or creatinine
level > 2 mg/dL
►Lactate dehydrogenase level > 2 folds of upper normal
limit
►Platelet count < 105/mm3
►Calcium level < 7.5 mg/dL
►C-reactive protein level > 15 mg/dL
►Systemic inflammatory response syndrome score > 3
►Age > 70 years old
Pancreas 2014, 43:487-89
38. BISAP: Bedside index for severity in acute
pancreatitis
Blood urea nitrogen >25 mg/dL
Impaired mental status (Glasgow coma scale score<15)
SIRS : SIRS is defined as two or more of the following:
►Temperature of <36℃ or >38℃
►Respiratory rate >20 breaths/min or PaCO2<32 mmHg
►Pulse>90 beats/min
►WBC<4×109 or >12×109/L or >10% immature bands
Age>60 yr
Pleural effusion detected on imaging
39. Clinical findings predicting a severe course
Patient characteristics
► Age > 55 years, Obesity (BMI > 30 kg / m2
)
► Altered mental status
Comorbid disease
The systemic infl ammatory response syndrome (SIRS)
►Presence of > 2 of the following criteria:
pulse > 90 beats / min, respirations > 20 / min, PaCO 2 > 32 mm
Hg, temperature > 38 ° C or < 36 ° C, WBC count > 12,000 or
< 4,000 cells / mm3
, 10 % immature neutrophils (bands)
Laboratory findings
► BUN > 20 mg/dl, Rising BUN, HCT > 44 %, Rising HCT, Elevated
creatinine
Radiology findings
► Pleural effusions, Pulmonary infiltrates, Multiple or extensive
extrapancreatic collections
ACG Guideline 2013. Am J Gastroenterol 2013
41. Issue 7 – Imaging in AP
CECT of abdomen in acute pancreatitis
►What are the findings which should especially be
taken into consideration?
►What is accuracy of CT scan?
►Should all patients be subjected to CT scan
examination?
►When should CT scan be done?
►What is the ideal timing?
►Does accuracy depend on timing and technique?
►What are the risks involved with CT scan
examination?
►What are the modalities to reduce the risk?
42. Contrast CT scan of abdomen
CECT provides over 90 % sensitivity and specificity for
the diagnosis of AP ( 20 ).
Routine use of CECT in patients with AP is unwarranted
If a patient fails to improve after 48 – 72 CECT or MRI
imaging is recommended to assess local complications
CT and MRI are comparable in the early assessment of
AP
►MRCP can detect CBD stones upto 3 mm
Timing of CT scan
►For assessment of severity and local complications:
after 3-5 days
►When diagnosis in doubt: any time
ACG Guideline. Am J Gastroenterol 2013; 108:1400–1415
43. CT severity index of acute pancreatitis
Balthazar CT Score
►A -Normal
► B -Focal or diffuse enlargement of the pancreas, including
irregularities of contour and inhomogeneous attenuation
► C - Pancreatic gland abnormalities in grade B plus per
pancreatic inflammation
► D - Grade C plus a single fluid collection
► E - Grade C plus 2 or more fluid collections and/or the
presence of gas in or adjacent to the pancreas
Necrosis
►None – score 0
►Less than 30% - score 2
►30-50% - score 4
►> 50% - score 6
44. Mortele KJ et al. AJR 2004;183:1261–1265
Modified CT Severity Index
48. Issue 8 – Antibiotic prophylaxis in AP
Antibiotics in acute panreatitis
►Should prophylactic antibiotics be given to all patients
with acute pancreatitis?
►Should prophylactic antibiotics be given to all patients
with severe acute pancreatitis?
►What are the commonly acceptable indications of
emperical use of antibiotics?
►What the antibiotics preferred for prophylactic or
emperical use?
►When to start and when to stop?
49. Prophylactic antibiotics in AP
“It is very difficult to study this very very challenging
question and it is likely to remain enigma for quite some
time”
Alphonso Brown, Gastroenterology 2004
50. Last 15 years
►Multiple trials
►Included mainly severe pancreatitis
►Many randomized trials, only one double blind
randomized trial
►Variable results
►Antibiotics : Imipenem, Cephalosporins,
Ciprofloxacin/Metronidazole
Prophylactic antibiotics in SAP
Gastroenterology 2004
51. Author Agent Durat
ion
Panrcreatic
infection
Mortality
Antibi
otics
Control Antibi
otics
Control
Pederzoli Imipenem 14 12.1 30.3 7.3 12.1
Sainio Cefuroxime 14 30.0 40.0 3.3 23.3
Delcenseri
e
Ceftazidime,
Amika, Metro
10 0 25 9.1 25
Schwarz Ofloxacin,
Metro
10 61.5 53.8 0 23
Nordback Imipenem/cila
statin
Not
state
d
8.0 42.4 8.0 15.1
Isenman Cipro, metro 14 12.0 8.9 5.1 7.1
Prophylactic antibiotics in AP
53. Antibiotics in acute pancreatitis
Routine use of prophylactic - not recommended
Prophylactic antibiotic in necrotizing pancreatitis - not
recommended
Antibiotics should be given for an extra-pancreatic infection
Infected necrosis should be considered in patients with
pancreatic or extrapancreatic necrosis who deteriorate or
fail to improve after 7 – 10 days of hospitalization.
► In these patients, either (i) initial CT-guided fine-needle
aspiration (FNA) for Gram stain and culture to guide use
of appropriate antibiotics or
►Empiric use of antibiotics after obtaining necessary
cultures for infectious agents, without CT FNA, should be
given
ACG Guideline . Am J Gastroenterology 2013
54. In patients with infected necrosis, antibiotics known to
penetrate pancreatic necrosis, such as carbapenems,
quinolones, and metronidazole, may be useful in delaying
or sometimes totally avoiding intervention, thus
decreasing morbidity and mortality
Duration of antibiotics : ??
Routine administration of antifungal agents along with
prophylactic or therapeutic antibiotics is not
recommended
Antibiotics in acute pancreatitis
ACG Guideline . Am J Gastroenterology 2013
55. Prophylactic antibiotics in AP
Mild pancreatitis : Not recommended
SAP: The prophylactic administration of
antibiotics may improve the prognosis, if
carried out in the early phases of pancreatitis
(within 72 h of onset). (2B)
Prophylactic antifungals are not recommended.
(1C)
Japanese Guideline. J Hepatobiliary Pancreat Sci (2015) 22:405–432
56. Antibiotics Efficacy factor
Imipenem 0.98%
Ofloxacin 0.87%
Ciprofloxacin 0.86%
Ceftriaxone 0.79%
Cefotaxime 0.78%
Tobramycin 0.22%
Netilmycin 0.21%
Efficacy factor of antibiotics in SAP
Trop GE 1998
57. Issue 9 – Nutrition in acute pancreatitis
Feeding in acute pancreatitis
►Which is the preferred route – enteral or parenteral?
►When to start feeding”?
►Mild to moderate pancreatitis
►Severe acute pancreatitis
►Which is preferred feeding formula –
elemental/polymeric/Immune feeding?
►Which is the preferred enteral feeding route –
nasogastric or nasoduodenal or nasojejunal?
58. Nutrition in acute pancreatitis
In mild AP, oral feedings can be started once there is no
nausea and vomiting, and abdominal pain
►low-fat solid diet appears as safe as a clear liquid diet
In severe AP, enteral nutrition is recommended to
prevent infectious complications.
Parenteral nutrition
►enteral route is not available, not tolerated, or not
meeting caloric requirements
Nasogastric delivery and nasojejunal delivery of enteral
feeding appear comparable in efficacy and safety
59. Nutrition in acute pancreatitis
Petrov M et al. ISRN Inflammation 2013
Reduced risk of infective complications and possibly
reduced mortality with enteral feeding in severe acute
pancreatitis
60. Nutrition in acute pancreatitis
Petrov M et al. ISRN Inflammation 2013
Most of the patients with SAP are able to tolerate enteral
feeding and nutritional goal is achieved in most patients
61. Enteral feeding formula
Elemental
►Comprising amino acids or oligopeptides,
maltodextrins, and medium—chain and long-chain
triglycerides;
Polymeric
►Comprising nonhydrolyzed proteins, maltodextrins,
and oligofructosaccharides, as well as long-chain
triglycerides;
Immune-enhancing
►Comprising substrates that have been hypothesised to
modulate the activity of the immune system, for
example, immunonutrition (glutamine, arginine, and
omega-3 fatty acids), probiotics, fibre-enriched
formulation.
62. Nutrition in Acute pancreatitis
Enteral nutrition –
►Curtails of acute inflammation of the pancreas
►Reduces septic complications
Nasojejunal tube feeding improves outcomes in SAP
Safety and efficacy of nasogastric tube feeding in SAP
Early NG feeding may have benefits even in mild-to-
moderate acute pancreatitis
Optimal enteral feeding formulations – more information is
required
Petrov M et al. ISRN Inflammation 2013
63. Put on IV antibiotics – Piperacillin+ Tazobactum for 14
days
Nasojejunal tube placed – feeding attempted
►Distension of abdomen
►SOB
Feeding had to be stopped temporarily
O2 supplementation
CXR was unremarkable
IAP was measured
Index case: Course
64. Issue 10 : IAP monitoring in acute
pancreatitis
Role of intra-abdominal pressure monitoring in acute
pancreatitis?
►How to define abdominal compartment syndrome?
►How to monitor for abdominal compartment syndrome?
►How to treat abdominal compartment syndrome?
65. Abdominal compartment syndrome
IAH – IAP> 12 mmHg ACS – IAP> 20 mmHg
Causes
►Inflammatory fluid collection, inflammatory mass
►Paralytic ileus and distension of bowel
►Ascites
Consequences
►Reduced renal and abd perfusion
►Ischemic bowel complication
►Respiratory impairment
Remedial measure
►Decompression of stomach & bowel
►Ascitic tap/ placement of drains
►Mechanical ventilation with muscle relaxants
►Restrict fluid if possible
Mentula P et al. World Journal of Emergency Surgery 2014, 9:15
66. NJ feeding could be established after 5 days
NJ feeding was given for two weeks
Oral feeding in third week – gradually built up
►Fullness and bloating – post meals
►No vomiting
Palpable lump abdomen, No fever , No vomiting
Labs: normal RFT, LFT, Mild leucocytosis
Discharged in 5th
week
Index case: Course
67. Re-evaluation during 7 – 8 th week
►Mild abdominal pain/discomfort, post prandial bloating
►No fever
►Tolerating oral diet, low fat
►Examination: large upper abdominal lump, mild
tenderness
Index case: Course
68.
69.
70. Issue 11 : Management of Non-Infected
Necrosis
Pancreatic necrosis without infection
►What are factors which determine the
outcome?
►What should be the preferred approach in
management?
72. Sterile pancreatic necrosis
Debridement for sterile necrosis is recommended if
►Associated with gastric outlet obstruction
►Bile duct obstruction
Asymptomatic pancreatic and / or extrapancreatic
necrosis does not mandate intervention regardless of
size, location, and extension.
73. 10th
week of illness
►Gradual increase in upper abdominal pain over 3-4
days
►Fever – High grade
►Vomitng off and on
►Shortness of breath
►Examination
Palpable upper abominal lump, tender
Reduced breath sound at lung bases
►Labs
RFT, LFT – N
HMG – Hb 10.5 gm, TLC – 24000, DLC – N88%, L
12
PCT – 3.9
Index case: Course
74.
75.
76. Issues 12: Infected Pancreatic Necrosis
Pancreatic necrosis - With evidence of infection
►Should all patients be referred for surgery?
►What are the factors which determine the outcome?
►How to select the cases for non-surgical
management?
►What is the optimum timing for surgery?
77. Issue
Infections in acute pancreatits
►What are the common sites of infection in patients
with acute pancreatitis?
►What are the risk factors for infected pancreatic
necrosis?
►Timing of pancreatic infection
►Methods of diagnosis
►Organisms
►What are the common organisms?
►What is the source of these organisms
►How common are the anaerobes?
►How common is fungal infection ?
78. Risk of pancreatic infection
Risk depends upon
►Severity of pancreatitis
Ranson’s score < 3 : 5.3%
Ranson’s score > 5 : 58%
►Extent of necrosis
<30% : 5-10%
30 – 50% : 10-20%
> 50% : 30 – 70%
►Bacterial colonization of gut
Br J Surgery 1999
80. Bacteriology of pancreatic infection
Organism Frequenc
y
E coli 35%
K pneumoniae 24%
Enterococcus 24%
Staphylococcus 14%
Pseudomonas 11%
Proteus 8%
Aerobic
streptococci
7%
Enterobacter 7%
Bacteroides 6%
Compiled data
No of series : 45
Total patients > 1100
Am Surgeon 2000
81. Fungal infection in pancreatic
necrosis
Risk factors
►Broad spectrum antibiotics
►Abdominal surgery
►Male sex, Age > 40 years
►Central venous access , Hypotension at admission
►High APACHE II score
►Renal failure , TPN, Respiratory failure at admission
►Mechanical ventilation
►ERCP/ Pancreatic stenting
►Diabetes mellitus
►Percutaneous drainage
►Duration of hospital stay > 4 weeks
Kochhar R, JGH 2013
83. Impact of pancreatic infection
Increased mortality
Increased morbidity
►Increased risk of renal failure
►Increased risk of GI bleed
►Increased risk of respiratory failure
►Increased cardiovascular complication
Longer hospital stay
Increased probability of surgery
Increased cost of therapy
85. Infection in pancreatic necrosis
When to suspect
►Timing : second or third week
►Clinical feature
Recurrence of pain abdomen
Worsening of organ system function
Increasing temperature
Increasing TLC
New onset ileus
Am Surgeon 2000
86. Methods of diagnosis
►Plain X-Ray
►Ultrasonography, CT
►Blood culture
►Gallium scan
►In111 labelled leucocyte scan
►USG/CT guided FNA
►PET CT
Infection in pancreatic necrosis
Gut 2005, Gastroenterology2004
87. Methods of diagnosis
►Plain X-Ray
►Ultrasonography, CT
►Blood culture
►Gallium scan
►In111 labelled leucocyte scan
►USG/CT guided FNA
►PET CT
Infection in pancreatic necrosis
Gut 2005, Gastroenterology2004
88. USG/CT guided FNA
Needle should not pass through a bowel
Each suspected area should be sampled, multiple passes
may be required
Multiple sessions may be required
Samples for gram’s stain, aerobic & anaerobic bacterial
culture, fungal smear & culture
Rapid inoculation, use of transport medium
90. Infected pancreatic necrosis
Antibiotics alone can lead to resolution of infection and,
in select patients, avoid surgery altogether
►16/28 pts improved with antibiotics
Unstable patients with infected necrosis needs
consideration for urgent debridement
►a course of antibiotics before intervention to allow the
inflammatory reaction to become better organized
►If pt fails to improve : Necrosectomy
Endoscopic/radiologic/video-assisted
retroperitoneal/ laparoscopic approach/
combination
91. Cochrane review
►The minimally invasive step-up approach resulted in
fewer adverse events, serious adverse events, less
organ failure, and lower costs compared to open
necrosectomy.
No evidence to suggest that early open necrosectomy is
superior or inferior to peritoneal lavage or delayed open
necrosectomy
Endoscopic minimally invasive step-up approach
resulted in fewer adverse events than the video-assisted
minimally invasive step-up approach but increased the
number of procedures required for treatment
Infected pancreatic necrosis
92. Treatment of Infected pancreatic necrosis
Before demarcation of necrosis develops (< 4 weeks), it
is almost impossible to remove all necrotic tissue without
causing hemorrhage.
Early surgical debridement
►High risk of hemorrhage
►Increased organ dysfunction and death.
Necrosectomy within the first two weeks - 75% mortality
Necrosectomy after 6-8 weeks – Mortality 5%
Multiple organ dysfunction increases mortality
93. Because high mortality is associated with early surgery ,
it is recommended that surgery for infected necrosis
should be postponed as late as possible, preferable later
than four week from disease onset
►Role of percutaneous drain – single or multiple
►Minimally invasive surgery/ endoscopic procedure
Infected pancreatic necrosis
94. Infected pancreatic necrosis
Supportive care for organ failure
Nutrition
Antibiotics : as per sensitivity and local data
Drainage and necrosectomy
►Open surgical
►Laparoscopic
►Radiological
►Endoscopic
95. USG guided aspiration
►Pus culture – E coli sensitive to Imipenem,
Meropenem and Colistin
Was started on Meropenem
PCD was places – upgraded to 16 F
Percutaneous endoscopic necrosectomy – 2 sessions
Patient became afebrile after first session
ERCP – Disrupted MPD, stented
Index case: Course
96. Necrosectomy for infected
necrosis
Best surgical method not defined
►No direct comparison available
Open surgical necrosectomy is the gold standard and
standard of care
Percutaneous and endoscopic necrosectomy are
emerging modalities
Local expertise and quality of ICU care matters
100. Issue 13
ERCP in acute biliary pancreatitis
►What are the indications for ERCP in acute biliary
pancreatitis?
Urgent indications
Semi-elective indications
►Does timing of ERCP matter?
►What is the preferred ERCP intervention – stent or
NBD or sphincterotomy or CBD clearance?
►Patient taken up for ERCP but no stone on
cholangiogram – what to do next?
102. ERCP in acute biliary pancreatitis
Indications
►Suspected bile-duct stones as the cause of
pancreatitis established clinically, and one of the
following:
Cholangitis (fever, jaundice, sepsis)
Persistent biliary obstruction (conjugated bilirubin
level >5 mg/dl
Clinical deterioration (worsening pain, increasing
white-cell count, worsening vital signs)
Stone detected in the common bile duct on imaging
ACG Guideline. Am J Gastroenterology 2013
103. Contraindications
►Absolute
Unstable medical condition precluding safe
administration of moderate sedation or general
anesthesia
Decision by competent patient not to provide consent
for the procedure
Endoscopist with inadequate training in ERCP
►Relative (may be overcome)
Anatomical condition (gastroduodenal disease or
surgical alteration) that would impede endoscopic
access to the major papilla;
Clinically significant or uncorrectable coagulopathy
ERCP in acute biliary pancreatitis
ACG Guideline. Am J Gastroenterology 2013
104. UK guideline 2005
►Early ERCP (within 72 hours after admission to the
hospital) in all patients with predicted or actual severe
biliary pancreatitis
AGA 2007
►Urgent ERCP (within 24 hours after admission) if
cholangitis
►Early ERCP (within 72 hours after admission) if suspicion
of persistent bile-duct stones
ACG 2013
►Patients with AP and concurrent acute cholangitis should
undergo ERCP within 24 h of admission
►ERCP is not needed early in most patients with gallstone
pancreatitis who lack laboratory or clinical evidence of
ongoing biliary obstruction
ERCP in acute biliary pancreatitis
105. ERCP in acute pancreatitis
Sphincterotomy and CBD clearance
►Evidence of CBD stone, biliary obstruction : at any
time during course
►Suspicion or evidence of cholangitis : at any time
during course
►Persistent biliary obstruction
►? Any case of biliary pancreatitis taken up for ERCP
106. ERCP in acute pancreatitis
“While laparoscopic cholecystectomy is the gold
standard to avoid recurrence in patients with gall
stone related pancreatitis, ERCP and sphincterotomy
are accepted alternatives in patients who are unfit for
surgery”
Gut 2005
107. Issue 14
Timing of cholecystectomy after an episode of acute
biliary pancreatitis?
► What is the risk of recurrence over time?
108. Risk of delayed cholecystectomy
Jee SL. Asian Journal of Surgery 2016
109. Summary
AP – disease with unpredictable severity
Significant morbidity and mortality in severe disease
Team approach is crucial in management
Enteral nutrition is preferable to parenteral nutrition
Radiological interventions may play a crucial role in
stabilizing a critically ill patient
Endoscopic interventions are indicated in a select group
of patient
Early surgery is associated with higher complication rate
compared with late surgery
Specific treatment should be instituted when applicable
114. AP: Magnitude of problem
Incidence : 4.9 – 73.4 cases per lac population
Incidence is increasing
Mortality: minimal decrease over years
Severity of pancreatitis
►Mild : 70 -80%
No local or systemic complication Usually no
necrosis
Recovery in 3 – 7 days
►Severe : 20 -30 %
Local or systemic complications
Necrosis usual
Infection : 20 – 70%
Gut 2005, Am J Gastro 2013
115. Course of acute pancreatitis
Overall mortality: 5 – 10%
Almost all mortality in severe cases
Two phases of illness
►Early phase - within 7 days: largely unrelated to
infection, mostly cytokine mediated
SIRS
Organ failure
►Late phase – after 7 days, largely related to infection
and consequences of organ failure
Local complications
Fluid collections, necrosis – sterile or infected
Acute pseudocyst
Walled off pancreatic necrosis
Organ failure - persistent
Tanner S et al. Am J Gastroenterol 2013
116. Cochior D et al. Chirurgia (2013) 108: 631-642
Course of acute pancreatitis
117. Initial assessment and risk stratification
Hemodynamic status be assessed immediately upon
presentation
►Aggressive hydration, defined as 250-500 ml per hour of
isotonic crystalloid solution preferably Ringer Lactate
Exceptions: Cardiovascular and renal comorbidity
►Higher infusion rate in those with hypotension or
tachycardia
►Assess fluid requirement every 6 hours for 48 hours –
aim to decrease BUN
Risk assessment :
►Stratify patients into higher- and lower-risk categories to
assist triage, such as admission to an intensive care
setting
Patients with organ failure:
►admitted to an ICU or HDU
118. APFC (acute peripancreatic fluid
collection)
Peripancreatic fluid associated with interstitial
oedematous pancreatitis with no associated
peripancreatic necrosis.
This term applies only to areas of peripancreatic fluid
seen within the first 4 weeks after onset of interstitial
oedematous pancreatitis and without the features of a
pseudocyst.
CECT criteria
►Occurs in the setting of interstitial oedematous
pancreatitis
►Homogeneous collection with fluid density
►Confined by normal peripancreatic fascial planes
►No definable wall encapsulating the collection
►Adjacent to pancreas (no intrapancreatic extension)
119. Pancreatic pseudocyst
An encapsulated collection of fluid with a well defined
inflammatory wall usually outside the pancreas with
minimal or no necrosis.
This entity usually occurs more than 4 weeks after onset
of interstitial oedematous pancreatitis to mature.
CECT criteria
►Well circumscribed, usually round or oval
►Homogeneous fluid density
►No non-liquid component
►Well defined wall; that is, completely encapsulated
►Maturation usually requires >4 weeks after onset of
acute pancreatitis; occurs after interstitial oedematous
pancreatitis
120. ANC (acute necrotic collection)
A collection containing variable amounts of both fluid and
necrosis associated with necrotising pancreatitis;
the necrosis can involve the pancreatic parenchyma
and/or the peripancreatic tissues
CECT criteria
►Occurs only in the setting of acute necrotizing
pancreatitis
►Heterogeneous and non-liquid density of varying
degrees in different locations (some appear
homogeneous early in their course)
►No definable wall encapsulating the collection
►Location—intrapancreatic and/or extrapancreatic
121. WON (walled-off necrosis)
A mature, encapsulated collection of pancreatic and/or
peripancreatic necrosis that has developed a well defined
inflammatory wall.
WON usually occurs >4 weeks after onset of necrotising
pancreatitis.
CECT criteria
►Heterogeneous with liquid and non-liquid density with
varying degrees of loculations (some may appear
homogeneous)
►Well defined wall, that is, completely encapsulated
►Location—intrapancreatic and/or extrapancreatic
►Maturation usually requires 4 weeks after onset of
acute necrotising pancreatitis
122. Etiology work up
Initial work up:
►Alcohol, Gall stones, Hypercalcemia,
hypertriglyceridemia
idiopathic acute pancreatitis,
►EUS - to assess for occult microlithiasis, neoplasms
and chronic pancreatitis.
►If EUS is negative, (secretin-stimulated) MRCP is
advised
For rare morphologic abnormalities - CT of the abdomen
If etiology remains unidentified, especially after a second
attack of idiopathic pancreatitis - genetic counseling (not
necessarily genetic testing)
ACG Guideline. Am J Gastroenterology 2013
123. Abdominal compartment syndrome
IAH – IAP> 12 mmHg ACS – IAP> 20 mmHg
Causes
►Inflammatory fluid collection, inflammatory mass
►Paralytic ileus and distension of bowel
►Ascites
Consequences
►Reduced renal and abd perfusion
►Ischemic bowel complication
►Respiratory impairment
Remedial measure
►Decompression of stomach & bowel
►Ascitic tap/ placement of drains
►Mechanical ventilation with muscle relaxants
►Restrict fluid if possible
Mentula P et al. World Journal of Emergency Surgery 2014, 9:15
126. EUS and acute pancreatitis
Fusaroli P et al. World J Gastroenterol 2012; 18(32): 4243-4256
127. Role of EUS in acute pancreatitis
EUS may prevent ERCP in 71% of patients with AP and
offers a complication-free alternative
EUS seems superior to MRCP (51% vs 20%) in the
evaluation of AP
Cholelithiasis and biliary sludge (24%) are the most
frequent EUS diagnoses, and pancreas divisum (8%) is
the most frequent MRCP diagnosis
EUS can diagnose underlying chronic pancreatitis
Treatment of local complication – fluid collection, FNA,
necrosectomy, pseudocyst drainage
131. Da Cost DW et al. BJS 2014;101:65-79
Management of Acute Pancreatitis
132. Japanese Guideline 2015
Urinary trypsinogen-2 dipstick may be useful for
minimally invasive method and rapid diagnosis of acute
pancreatitis.
The prophylactic administration of antibiotics in severe
acute pancreatitis and necrotizing pancreatitis may
improve the prognosis, if carried out in the early phases
of pancreatitis (within 72 h of onset). (2B)
Intravenous hyperalimentation is not recommended for
mild cases. (1B)
In severe cases, it is more significant as a measure to
prevent infection rather than as a route of nutrition
support.
If initiated in the early phase, enteral nutrition can reduce
133. In principle, it is recommended that enteral feeding tubes
be inserted into the jejunum through the Treitz ligament.
However, if a feeding tube cannot be inserted into the
jejunum, nutrients can be infused into the duodenum or
stomach instead. (2B)
No life-saving effect has been observed from peritoneal
lavage for acute pancreatitis
The sequential measurement of IAP is recommended for
cases with
►excessive fluid infusion, high severity,
►renal and respiratory complications,
►fluid accumulation in multiple areas as observed by CT,
Japanese Guideline 2015
134. When there is persistent or recurrent IAP≧12mmHg,
►gastrointestinal decompression,
►intra-abdominal decompression,
►improvement of abdominal wall compliance,
►appropriate fluid infusion and circulation management
Surgical decompression should be considered only when
internal treatment is not effective for patients with
IAP>20mmHg and where the additional complication of
organ failure is of concern
Routine use of FNA is not required for diagnosis, and
clinical signs and CT should be used for a
comprehensive determination.
Japanese Guideline 2015
135. If possible, therapeutic intervention for infected
pancreatic necrosis should be performed after 4 weeks of
onset, when the necrosis has been sufficiently walled off,
or in other words, during WON period
for infected pancreatic necrosis, percutaneous
(retroperitoneal) drainage or endoscopic transluminal
drainage should be first given, and if no improvement is
achieved, necrosectomy should then be performed
Japanese Guideline 2015
145. Probiotics in acute pancreatitis
Four RCTs (n=428) were included in the review. Sample
size ranged from 25 to 296 participants.
The present study showed that enteral feeding with
probiotics could not reduce rates of infected necrosis
and mortality. Future studies were required
Langenbeck's Archives of Surgery 2009; 394(1): 171-177